Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictor for Re-treatment of Overactive Bladder Syndrome After Discontinuation of Mirabegron Treatment for Female Overactive Bladder Syndrome

NCT04550702 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04550702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04550702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictor for Re-treatment of Overactive Bladder Syndrome After Discontinuation of Mirabegron Treatment for Female Overactive Bladder Syndrome
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
July 31, 2019
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrence of overactive bladder syndrome